Cargando…
MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma
Renal cell carcinoma (RCC) incidence has increased over the past two decades. Recent studies reported microRNAs as promising biomarkers for early cancer detection, accurate prognosis, and molecular targets for future treatment. This study aimed to evaluate the expression levels of miR-34a and 11 of...
Autores principales: | Toraih, Eman A., Ibrahiem, Afaf T., Fawzy, Manal S., Hussein, Mohammad H., Al-Qahtani, Saeed Awad M., Shaalan, Aly A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632457/ https://www.ncbi.nlm.nih.gov/pubmed/29104726 http://dx.doi.org/10.1155/2017/3269379 |
Ejemplares similares
-
Analysis of microRNA-34a expression profile and rs2666433 variant in colorectal cancer: a pilot study
por: Fawzy, Manal S., et al.
Publicado: (2020) -
MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma
por: Fawzy, Manal S., et al.
Publicado: (2023) -
GLUT1 and ASCT2 Protein Expression in Papillary Thyroid Carcinoma Patients and Relation to Hepatitis C Virus: A Propensity-Score Matched Analysis
por: Ibrahiem, Afaf T, et al.
Publicado: (2022) -
Prognostic Value of LINC-ROR (rs1942347) Variant in Patients with Colon Cancer Harboring BRAF Mutation: A Propensity Score-Matched Analysis
por: Shaalan, Aly A. M., et al.
Publicado: (2022) -
Prognostic value of BRAF/MIR‐17 signature and B‐Raf protein expression in patients with colorectal cancer: A pilot study
por: Ibrahiem, Afaf T., et al.
Publicado: (2020)